Affiliation:
1. Neurosurgery Service, Memorial Sloan-Kettering Cancer Center and the Department of Neurological Surgery, Weill Medical College of Cornell University, New York, New York
Abstract
ABSTRACT
ATYPICAL AND ANAPLASTIC meningiomas are uncommon tumors with a poorer prognosis than benign meningiomas. We reviewed the current literature and attempted to integrate and summarize available information to determine a logical approach to these tumors. Both tumors are rare and are often integrated with benign meningiomas when treatments are evaluated. In addition, because there has not been one histopathological classification scheme for atypical and anaplastic meningiomas in the past, there are numerous inconsistencies in the literature. Malignant progression with accumulation of mutations in a benign meningioma can result in an atypical and/or anaplastic meningioma. Both tumors are difficult to manage and have high recurrence and poor survival rates. The extent of tumor resection and histological grade are the key determinants for recurrence. In addition, metastases are unusual, but they do occur. We also review the evidence available that has resulted in the current World Health Organization classification. Radiation therapy can be used as an adjunctive treatment after both total and subtotal resection. In addition, the role of stereotactic radiosurgery is increasing, along with a possible role for brachytherapy. There are no effective chemotherapeutic agents available. A treatment algorithm is suggested.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Clinical Neurology,Surgery
Reference66 articles.
1. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: A study of 90 tumors.;Abramovich;Hum Pathol,1998
2. Malignant progression in meningioma: Documentation of a series and analysis of cytogenetic findings.;Al-Mefty;J Neurosurg,2004
3. Radiation-induced meningiomas: Clinical, pathological, cytokinetic, and cytogenetic characteristics.;Al-Mefty;J Neurosurg,2004
4. Platelet derived growth factor expression and stimulation in human meningiomas.;Black;J Neurosurg,1994
5. Alterations of the tumor suppressor genes CDKN2A (p16 (INK4a)), p14 (ARF), CDKN2B (p15 (INK4b)), and CDKN2C (p18 (INK4c)) in atypical and anaplastic meningiomas;Bostrom;Am J Pathol,2001
Cited by
277 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献